Skip to content
2000
Volume 24, Issue 3
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Introduction

Remimazolam is a novel benzodiazepine derivative with advantages such as prompt onset, short duration of action, fast recovery, and non-organ dependence. Numerous studies have been conducted on remimazolam. However, bibliometric analysis on high-quality and highly cited articles related to remimazolam is lacking. The objective of this article is to evaluate the current research status and prevailing trends regarding the most frequently cited articles on remimazolam, utilizing bibliometrics.

Methods

Studies related to remimazolam were searched in the Web of Science core database. The search period ranged from the inception of the database to April 2025, and 100 highly cited research articles were selected. The researchers gathered and analyzed pertinent data from the studies and subsequently conducted visual analysis utilizing VOSviewer and CiteSpace.

Results

The total number of citations for the top 100 highly cited studies was 6683, published between 2010 and 2024. China, the United States, and the United Kingdom contributed the majority of these studies. These studies were published in 47 different journals. The journal with the highest number of publications was the . The institution with the highest publication volume was PAION DEUTSCHLAND GMBH in Germany, and the author with the highest contribution was Schippers F. The pharmacokinetics, pharmacodynamics, safety, and efficacy of remimazolam were the main research directions and focuses in the field.

Discussion

Our analysis of the top 100 cited remimazolam papers reveals a rapidly advancing field. The surge in high-quality clinical studies confirms remimazolam's practical edge over older agents, such as propofol, particularly in offering better blood pressure stability for older patients and fewer breathing problems during procedures like endoscopy. While these advantages position it as a strong contender, important questions linger about its use in people with severe liver or kidney issues due to how it is broken down, and its effects on delirium remain unclear. Broadening research globally and focusing on these specific patient groups, as well as long-term safety, will be key to realizing remimazolam's full clinical potential.

Conclusion

This study analyzed the 100 most frequently referenced articles on remimazolam, providing valuable insights into the characteristics and focal areas of research related to this topic.

Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X370775250704060228
2025-07-24
2026-02-26
Loading full text...

Full text loading...

References

  1. MonanianG. YonelB. RupertD. RazakA. DeLemosM. BergeseS.D. Evaluating remimazolam for procedural sedation.Curr. Neuropharmacol.20252391009102010.2174/011570159X367968250117034551 39936418
    [Google Scholar]
  2. HuQ. LiuX. WenC. LiD. LeiX. Remimazolam: An updated review of a new sedative and anaesthetic.Drug Des. Devel. Ther.2022163957397410.2147/DDDT.S384155 36411859
    [Google Scholar]
  3. KilpatrickG.J. Remimazolam: Non-clinical and clinical profile of a new sedative/anesthetic agent.Front. Pharmacol.20211269087510.3389/fphar.2021.690875 34354587
    [Google Scholar]
  4. SneydJ.R. Remimazolam – current status, opportunities and challenges.Anesthesiol. Perioperative Sci.2023132510.1007/s44254‑023‑00021‑7
    [Google Scholar]
  5. ChangY. HuangY.T. ChiK.Y. HuangY.T. Remimazolam versus propofol for procedural sedation: A meta-analysis of randomized controlled trials.PeerJ202311e1549510.7717/peerj.15495 37334113
    [Google Scholar]
  6. ZhaoM. HuH. LiX. LiX. WangD. KuangM. The safety and efficacy between remimazolam and propofol in intravenous anaesthesia of endoscopy operation: A systematic review and meta-analysis.Int. J. Surg.2023109113566357710.1097/JS9.0000000000000638 37534687
    [Google Scholar]
  7. DouD. FengY. JiangL. Efficiency and safety of remimazolam and midazolam in digestive endoscopic sedation: Systematic review and meta‐analysis.Dig. Endosc.202234365310.1111/den.14219 34918386
    [Google Scholar]
  8. KimS.H. ChoJ.Y. KimM. ChungJ.M. YangJ. SeongC. KimE.G. SeokJ.W. ShinY.M. LeeK.M. ChoeK.H. HanJ.H. YangB. Safety and efficacy of remimazolam compared with midazolam during bronchoscopy: A single-center, randomized controlled study.Sci. Rep.20231312049810.1038/s41598‑023‑47271‑w 37993525
    [Google Scholar]
  9. ZhangX. LiH.X. ChenY.R. WangB.N. ZhengH. YanT. Safety and efficacy of remimazolam compared with propofol for general anesthesia during cold knife conization: A single-center, randomized controlled trial.BMC Anesthesiol.202525119710.1186/s12871‑025‑03066‑2 40269691
    [Google Scholar]
  10. WangZ. ZhanR. MoL. ZhangJ. HuJ. TanS. HeQ. LiP. SunW. WangX. JiangJ. LiuL. ZhangY. BaiY. Comparison of effect of remimazolam and propofol on respiration of patients under deep sedation for colonoscopy: A prospective multicenter randomized controlled trial.Eur. J. Med. Res.202530125010.1186/s40001‑025‑02519‑1 40189570
    [Google Scholar]
  11. XinY. LuP. GuanS. SiS. SunR. XiaW. XuH. Efficacy and safety of remimazolam in short endoscopic procedures: A systematic review and meta-analysis.Medicina (Kaunas)202561345310.3390/medicina61030453 40142264
    [Google Scholar]
  12. KilpatrickG.J. McIntyreM.S. CoxR.F. StaffordJ.A. PacofskyG.J. LovellG.G. WiardR.P. FeldmanP.L. CollinsH. WaszczakB.L. TilbrookG.S. CNS 7056: A novel ultra-short-acting Benzodiazepine.Anesthesiology20071071606610.1097/01.anes.0000267503.85085.c0 17585216
    [Google Scholar]
  13. KeamS.J. Remimazolam: First approval.Drugs202080662563310.1007/s40265‑020‑01299‑8 32274703
    [Google Scholar]
  14. AdministrationN.M.P. Annual Report on Drug Review.2019Available from https://www.nmpa.gov.cn/
    [Google Scholar]
  15. MinJ.J. OhE.J. HwangH.J. JoS. ChoH. KimC. LeeJ.H. Hypotension after induction of anesthesia with remimazolam or etomidate: A non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting.Korean J. Anesthesiol.202578213914710.4097/kja.24537 39748752
    [Google Scholar]
  16. HorikoshiY. KurataniN. TatenoK. HoshijimaH. NakamuraT. MiedaT. DoiK. NagasakaH. Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy.Medicine (Baltimore)202110049e2820910.1097/MD.0000000000028209 34889305
    [Google Scholar]
  17. PetkusH. WillerB.L. TobiasJ.D. Remimazolam in a pediatric patient with a suspected family history of malignant hyperthermia.J. Med. Cases202213838639010.14740/jmc3977 36128061
    [Google Scholar]
  18. ZhuK. WuS. HaoX. WangC. Successful sedation with remimazolam and alfentanil in a child susceptible to malignant hyperthermia: A case report.BMC Anesthesiol.202525120710.1186/s12871‑025‑03076‑0 40269725
    [Google Scholar]
  19. YangX. LinC. ChenS. HuangY. ChengQ. YaoY. Remimazolam for the prevention of emergence delirium in children following tonsillectomy and adenoidectomy under sevoflurane anesthesia: A randomized controlled study.Drug Des. Devel. Ther.2022163413342010.2147/DDDT.S381611 36203819
    [Google Scholar]
  20. BrüggemannV. HansenT.G. Remimazolam for sedation and anesthesia in children: Protocol for a scoping review.Acta Anaesthesiol. Scand.202468684885110.1111/aas.14411 38504555
    [Google Scholar]
  21. ZhouT. QuJ. SunH. XueM. ShenY. LiuY. Research trends and hotspots on montessori intervention in patients with dementia from 2000 to 2021: A bibliometric analysis.Front. Psychiatry20211273727010.3389/fpsyt.2021.737270 34566730
    [Google Scholar]
  22. LiT. YangA. LiuG. ZouS. ChenY. NiB. LiuY. FanJ. Status quo and research trends of craniopharyngioma research: A 10-year bibliometric analyses (From 2011 to 2020).Front. Oncol.20211174430810.3389/fonc.2021.744308 34660308
    [Google Scholar]
  23. AbushammaF. BarqawiA. Al-JabiS.W. AkkawiM. MareeM. ZyoudS.H. Global analysis of research trends on kidney function after nephron-sparing surgery: A bibliometric and visualised study.Cancer Manag. Res.2021137479748710.2147/CMAR.S324284 34611441
    [Google Scholar]
  24. NinkovA. FrankJ.R. MaggioL.A. Bibliometrics: Methods for studying academic publishing.Perspect. Med. Educ.202111317317610.1007/S40037‑021‑00695‑4 34914027
    [Google Scholar]
  25. YiK. XuJ.G. YangK.L. ZhangX. MaL. YouT. TianJ.H. The top-100 most cited articles of biomarkers in congenital heart disease: A bibliometric analysis.Ann. Palliat. Med.20221151700171310.21037/apm‑21‑2422 35016519
    [Google Scholar]
  26. PowellA.G.M.T. HughesD.L. WheatJ.R. LewisW.G. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis.Int. J. Surg.201628839010.1016/j.ijsu.2016.02.028 26873521
    [Google Scholar]
  27. VaishyaR. GuptaB.M. MisraA. MamdapurG.M.N. WalkeR. VaishA. Top 100 highly cited papers from India on COVID-19 research: A bibliometric analysis of the core literature.Diabetes Metab. Syndr.2023171110289810.1016/j.dsx.2023.102898 37952296
    [Google Scholar]
  28. WanZ. WangT. LuP. ShuC. Bibliometric analysis of the top 100 most-cited articles on branch reconstruction in endovascular aortic repair.Asian J. Surg.202447148649610.1016/j.asjsur.2023.06.124 37423856
    [Google Scholar]
  29. ChenL. LiN. ZhangY. High-impact papers in the field of anesthesiology: A 10-year cross-sectional study.Can. J. Anaesth.202370218319010.1007/s12630‑022‑02363‑5 36418743
    [Google Scholar]
  30. HuX. WangB. HuL. HanD. WuJ. Bibliometric analysis of global trends in remimazolam-related research over the past 15 years: Compared with propofol.Drug Des. Devel. Ther.2023172119213510.2147/DDDT.S411829 37496748
    [Google Scholar]
  31. GodinB.J.S. On the origins of bibliometrics.Scientometrics200668110913310.1007/s11192‑006‑0086‑0
    [Google Scholar]
  32. LeeA. ShirleyM. Remimazolam: A review in procedural sedation.Drugs202181101193120110.1007/s40265‑021‑01544‑8 34196946
    [Google Scholar]
  33. WangZ. HuZ. DaiT. The comparison of propofol and midazolam for bronchoscopy.Medicine (Baltimore)20189736e1222910.1097/MD.0000000000012229 30200147
    [Google Scholar]
  34. TriantafillidisJ.K. MerikasE. NikolakisD. PapaloisA.E. Sedation in gastrointestinal endoscopy: Current issues.World J. Gastroenterol.201319446348110.3748/wjg.v19.i4.463 23382625
    [Google Scholar]
  35. CohenL.B. WecslerJ.S. GaetanoJ.N. BensonA.A. MillerK.M. DurkalskiV. AisenbergJ. Endoscopic sedation in the United States: Results from a nationwide survey.Am. J. Gastroenterol.2006101596797410.1111/j.1572‑0241.2006.00500.x 16573781
    [Google Scholar]
  36. FroehlichF. HarrisJ. WietlisbachV. BurnandB. VaderJ.P. GonversJ.J. Current sedation and monitoring practice for colonoscopy: An International Observational Study (EPAGE).Endoscopy200638546146910.1055/s‑2006‑925368 16767580
    [Google Scholar]
  37. VargoJ.J. DeLeggeM.H. FeldA.D. GerstenbergerP.D. KwoP.Y. LightdaleJ.R. NuccioS. RexD.K. SchillerL.R. Multisociety sedation curriculum for gastrointestinal endoscopy.Gastrointest. Endosc.2012761e1e2510.1016/j.gie.2012.03.001 22624793
    [Google Scholar]
  38. MuiL. TeohA.Y.B. NgE.K.W. LeeY. Au YeungA.C.M. ChanY. LauJ.Y.W. ChungS.C.S. Premedication with orally administered midazolam in adults undergoing diagnostic upper endoscopy: A double-blind placebo-controlled randomized trial.Gastrointest. Endosc.200561219520010.1016/S0016‑5107(04)02590‑8 15729225
    [Google Scholar]
  39. CohenL.B. HightowerC.D. WoodD.A. MillerK.M. AisenbergJ. Moderate level sedation during endoscopy: A prospective study using low-dose propofol, meperidine/fentanyl, and midazolam.Gastrointest. Endosc.200459779580310.1016/S0016‑5107(04)00349‑9 15173791
    [Google Scholar]
  40. VargoJ.J. ZuccaroG. DumotJ.A. MorrowJ.B. ConwellD.L. TrolliP.A. ShermockK.M. MaurerW.G. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: A prospective, randomized trial.Gastroenterology2002123181610.1053/gast.2002.34232 12105827
    [Google Scholar]
  41. UlmerB.J. HansenJ.J. OverleyC.A. SymmsM.R. ChadalawadaV. LiangpunsakulS. StrahlE. MendelA.M. RexD.K. Propofol versus midazolam/fentanyl for outpatient colonoscopy: Administration by nurses supervised by endoscopists.Clin. Gastroenterol. Hepatol.20031642543210.1016/S1542‑3565(03)00226‑X 15017641
    [Google Scholar]
  42. SipeB.W. RexD.K. LatinovichD. OverleyC. KinserK. BratcherL. KarekenD. Propofol versus midazolam/meperidine for outpatient colonoscopy: Administration by nurses supervised by endoscopists.Gastrointest. Endosc.200255781582510.1067/mge.2002.124636 12024134
    [Google Scholar]
  43. MadanH.K. SinghR. SodhiG.S. Comparsion of intravenous lignocaine, tramadol and keterolac for attenuation of propofol injection pain.J. Clin. Diagn. Res.2016107UC05UC0810.7860/JCDR/2016/20444.8118 27630928
    [Google Scholar]
  44. MarikP. Propofol: Therapeutic indications and side-effects.Curr. Pharm. Des.200410293639364910.2174/1381612043382846 15579060
    [Google Scholar]
  45. PastisN.J. YarmusL.B. SchippersF. OstroffR. ChenA. AkulianJ. WahidiM. ShojaeeS. TannerN.T. CallahanS.P. FeldmanG. LorchD.G. NdukwuI. PritchettM.A. SilvestriG.A. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy.Chest2019155113714610.1016/j.chest.2018.09.015 30292760
    [Google Scholar]
  46. RexD.K. BhandariR. DestaT. DeMiccoM.P. SchaefferC. EtzkornK. BarishC.F. PruittR. CashB.D. QuirkD. TiongcoF. SullivanS. BernsteinD. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.Gastrointest. Endosc.2018883427437.e610.1016/j.gie.2018.04.2351 29723512
    [Google Scholar]
  47. PambiancoD.J. BorkettK.M. RiffD.S. WinkleP.J. SchwartzH.I. MelsonT.I. Wilhelm-OgunbiyiK. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.Gastrointest. Endosc.201683598499210.1016/j.gie.2015.08.062 26363333
    [Google Scholar]
  48. WorthingtonM.T. AntonikL.J. GoldwaterD.R. LeesJ.P. Wilhelm-OgunbiyiK. BorkettK.M. MitchellM.C. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.Anesth. Analg.201311751093110010.1213/ANE.0b013e3182a705ae 24108261
    [Google Scholar]
  49. ChenS. WangJ. XuX. HuangY. XueS. WuA. JinX. WangQ. LyuJ. WangS. LiY. YuY. AiD. LuoA. MinS. LiL. ZouX. LiuJ. LvP. ChaiX. SunX. ZhaoZ. ZhangJ. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: A multicentered, randomized, positive-controlled, phase III clinical trial.Am. J. Transl. Res.202012845944603 32913533
    [Google Scholar]
  50. KlotzU. Pharmacokinetics and drug metabolism in the elderly.Drug Metab. Rev.2009412677610.1080/03602530902722679 19514965
    [Google Scholar]
  51. LimB.G. LeeI.O. Anesthetic management of geriatric patients.Korean J. Anesthesiol.202073182910.4097/kja.19391 31636241
    [Google Scholar]
  52. KuangQ. ZhongN. YeC. ZhuX. WeiF. Propofol versus remimazolam on cognitive function, hemodynamics, and oxygenation during one-lung ventilation in older patients undergoing pulmonary lobectomy: A randomized controlled trial.J. Cardiothorac. Vasc. Anesth.202337101996200510.1053/j.jvca.2023.06.027 37422336
    [Google Scholar]
  53. HuB. JiangK. ShiW. XiaoS. ZhangS. ZhangY. ZhouY. TanC. TanS. ZouX. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy: A multicentered, prospective, and randomized study.Drug Des. Devel. Ther.2022164151415910.2147/DDDT.S391147 36506792
    [Google Scholar]
  54. TianY. ChenD. ZhangH. SunY. Comparative analysis of the therapeutic efficacy of remimazolam tosylate and propofol in older adults undergoing painless endoscopic retrograde cholangiopancreatography.Front. Pharmacol.202415140453610.3389/fphar.2024.1404536 39484164
    [Google Scholar]
  55. JeonY.G. KimS. ParkJ.H. LeeJ. SongS.A. LimH.K. SongS.W. Incidence of intraoperative hypotension in older patients undergoing total intravenous anesthesia by remimazolam versus propofol: A randomized controlled trial.Medicine (Baltimore)202310249e3644010.1097/MD.0000000000036440 38065872
    [Google Scholar]
  56. ChaiB. GuoJ. XuZ. ChenT. WangH. ZhuZ. ZhongJ. ChenK. DuJ. KangX. Comparison of the efficacy and safety of remimazolam and propofol for fiberoptic bronchoscopy in older patients: A prospective, randomized controlled study.BMC Geriatr.202525133710.1186/s12877‑025‑05984‑9 40369438
    [Google Scholar]
  57. LuY. WuJ. LanH. XuQ. ShiS. DuanG. Efficacy and safety of general anesthesia induction with ciprofol in hip fracture surgery of elderly patients: A randomized controlled trial.Drug Des. Devel. Ther.2024183951395810.2147/DDDT.S475176 39247794
    [Google Scholar]
  58. CaoY. ChiP. ZhouC. LvW. QuanZ. XueF.S. Errate: Remimazolam tosilate sedation with adjuvant sufentanil in chinese patients with liver cirrhosis undergoing gastroscopy: A randomized controlled study.Med. Sci. Monit.202228e93839910.12659/MSM.938399 36111483
    [Google Scholar]
  59. GuoJ. QianY. ZhangX. HanS. ShiQ. XuJ. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study.BMC Anesthesiol.202222118010.1186/s12871‑022‑01713‑6 35689208
    [Google Scholar]
  60. ChoeJ.W. ChungM.J. ParkS.W. OhD. HanS.Y. YangM.J. KimE.J. ChoJ.H. LeeK.J. JangS.I. Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study.Gastrointest. Endosc.20241002183191.e110.1016/j.gie.2024.04.001 38580132
    [Google Scholar]
  61. KoC.C. HungK.C. IlliasA.M. ChiuC.C. YuC.H. LinC.M. ChenI.W. SunC.K. The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis.Front. Pharmacol.202314110172810.3389/fphar.2023.1101728 36814492
    [Google Scholar]
  62. AntonikL.J. GoldwaterD.R. KilpatrickG.J. TilbrookG.S. BorkettK.M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.Anesth. Analg.2012115227428310.1213/ANE.0b013e31823f0c28 22190555
    [Google Scholar]
  63. SongJ. YuW. ChenS. HuangJ. ZhouC. LiangH. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury.Eur. J. Pharmacol.202496617634210.1016/j.ejphar.2024.176342 38290569
    [Google Scholar]
  64. ShiF. ChenY. LiH. ZhangY. ZhaoT. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation.Int. J. Gen. Med.20221558359110.2147/IJGM.S345390 35046716
    [Google Scholar]
  65. UchidaS. TakekawaD. HashibaE. KudoR. HirotaK. Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report.JA Clin. Rep.2022819910.1186/s40981‑022‑00590‑9 36572840
    [Google Scholar]
  66. StöhrT. ColinP.J. OssigJ. PesicM. BorkettK. WinkleP. StruysM.M.R.F. SchippersF. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment.Br. J. Anaesth.2021127341542310.1016/j.bja.2021.05.027 34246461
    [Google Scholar]
  67. MaoQ. LiangB. LengZ. MaW. ChenY. XieY. Remimazolam ameliorates postoperative cognitive dysfunction after deep hypothermic circulatory arrest through HMGB1-TLR4-NF-κB pathway.Brain Res. Bull.202421711108610.1016/j.brainresbull.2024.111086 39322086
    [Google Scholar]
  68. ZhouZ. YangY. WeiY. XieY. Remimazolam attenuates lps-derived cognitive dysfunction via subdiaphragmatic vagus nerve target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway.Neurochem. Res.20244951306132110.1007/s11064‑024‑04115‑x 38472553
    [Google Scholar]
  69. ZhouL. ShiH. XiaoM. LiuW. WangL. ZhouS. ChenS. WangY. LiuC. Remimazolam attenuates lipopolysaccharide-induced neuroinflammation and cognitive dysfunction.Behav. Brain Res.202547611526810.1016/j.bbr.2024.115268 39322063
    [Google Scholar]
  70. YangJ.J. LeiL. QiuD. ChenS. XingL.K. ZhaoJ.W. MaoY.Y. YangJ.J. Effect of remimazolam on postoperative delirium in older adult patients undergoing orthopedic surgery: A prospective randomized controlled clinical trial.Drug Des. Devel. Ther.20231714315310.2147/DDDT.S392569 36712948
    [Google Scholar]
  71. CaiY.H. ZhongJ.W. MaH.Y. SzmukP. WangC.Y. WangZ. ZhangX.L. DongL.Q. LiuH.C. Effect of remimazolam on emergence delirium in children undergoing laparoscopic surgery: A double-blinded randomized trial.Anesthesiology2024141350051010.1097/ALN.0000000000005077 38758221
    [Google Scholar]
  72. TerresM.T. AssisM.L. Da SilveiraC.B. AmaralS. Remimazolam versus propofol for endoscopy sedation in elderly patients: A systematic review, meta-analysis and trial sequential analysis.Minerva Anestesiol.202490977578410.23736/S0375‑9393.24.18027‑3 38775443
    [Google Scholar]
  73. ZhuH. SuZ. ZhouH. LuJ. WangX. JiZ. ChenS. WangX. YaoM. LuY. YuW. SuD. Remimazolam dosing for gastroscopy: A randomized noninferiority trial.Anesthesiology2024140340941610.1097/ALN.0000000000004851 38039392
    [Google Scholar]
  74. JhuangB.J. YehB.H. HuangY.T. LaiP.C. Efficacy and safety of remimazolam for procedural sedation: A meta-analysis of randomized controlled trials with trial sequential analysis.Front. Med. (Lausanne)2021864186610.3389/fmed.2021.641866 34386505
    [Google Scholar]
  75. SneydJ.R. Rigby-JonesA.E. Remimazolam for anaesthesia or sedation.Curr. Opin. Anaesthesiol.202033450651110.1097/ACO.0000000000000877 32530890
    [Google Scholar]
/content/journals/cn/10.2174/011570159X370775250704060228
Loading
/content/journals/cn/10.2174/011570159X370775250704060228
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test